Ted W. Love

Ted W. Love, MD, currently serves as a Senior Consultant at Pfizer and a Board Member at Structure Therapeutics and Royalty Pharma. Additionally, Ted holds the position of Immediate Past Chairman of the Board for the Biotechnology Innovation Organization, where leadership was previously extended as Chairman from June 2019 to June 2023. Ted's extensive experience includes a tenure as President & CEO at Global Blood Therapeutics, focusing on the development of voxelotor for sickle cell disease. Ted's board memberships span multiple organizations, including Seagen, Portola Pharmaceuticals, and Amicus Therapeutics. Educational credentials include a Fellowship in Cardiology and a Residency in Internal Medicine from Harvard Medical School, an MD from Yale School of Medicine, and a B.A. in Molecular Biology from Haverford College.